Prodrugs of sulfide and persulfide species: Implications in their different pharmacological activities

Curr Opin Chem Biol. 2023 Jun 4;75:102329. doi: 10.1016/j.cbpa.2023.102329. Online ahead of print.ABSTRACTReactive sulfur species (RSS), such as H2S, hydrogen polysulfide (H2Sn, n ≥ 2), and hydropersulfides (RSSnH, n ≥ 1), are known to mediate diverse signaling pathways and possess a plethora of exciting therapeutic opportunities. Historically, due to the rapid inter-conversion among those species in vivo, the biological differences of distinct sulfur species were often overlooked. These species were considered to enrich the global sulfur pool in almost an equal fashion. However, advancement in this field has revealed that sulfur species at different oxidation states result in different pharmacological effects including scavenging reactive oxygen species (ROS), activating ion channels, and exhibiting analgesic effects. Here, we summarize recent advances in studying the biological and pharmacological differences of distinct sulfur species; discuss this phenomenon from the view of chemical properties and sulfur signaling pathways; and lay out a roadmap to transforming such new knowledge into general principles in developing sulfur-based therapeutics.PMID:37279623 | DOI:10.1016/j.cbpa.2023.102329
Source: Current Opinion in Chemical Biology - Category: Biochemistry Authors: Source Type: research